Eopinex Ltd 12939628 false 2022-11-01 2023-10-31 2023-10-31 The principal activity of the company is to provide medical services. Digita Accounts Production Advanced 6.30.9574.0 true 12939628 2022-11-01 2023-10-31 12939628 2023-10-31 12939628 bus:Original 2023-10-31 12939628 core:CurrentFinancialInstruments core:WithinOneYear 2023-10-31 12939628 bus:Micro-entities 2022-11-01 2023-10-31 12939628 bus:AuditExemptWithAccountantsReport 2022-11-01 2023-10-31 12939628 bus:FullAccounts 2022-11-01 2023-10-31 12939628 bus:SmallCompaniesRegimeForAccounts 2022-11-01 2023-10-31 12939628 bus:RegisteredOffice 2022-11-01 2023-10-31 12939628 bus:Director1 2022-11-01 2023-10-31 12939628 bus:Director2 2022-11-01 2023-10-31 12939628 bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 12939628 countries:England 2022-11-01 2023-10-31 12939628 2021-11-01 2022-10-31 12939628 2022-10-31 12939628 core:CurrentFinancialInstruments core:WithinOneYear 2022-10-31 iso4217:GBP xbrli:pure

Registration number: 12939628

Eopinex Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 October 2023

 

Eopinex Ltd

(Registration number: 12939628)
Balance Sheet as at 31 October 2023

2023
£

2022
£

Current assets

217,117

172,361

Creditors: Amounts falling due within one year

(84,065)

(94,124)

Total assets less current liabilities

133,052

78,237

Accruals and deferred income

(1,950)

(1,950)

 

131,102

76,287

Capital and reserves

131,102

76,287

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
80-83 Long Lane
London
EC1A 9ET
United Kingdom

These financial statements were authorised for issue by the Board on 8 March 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2022 - 2).

For the financial year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the Board on 8 March 2024 and signed on its behalf by:
 

 

Eopinex Ltd

(Registration number: 12939628)
Balance Sheet as at 31 October 2023

.........................................
Mahinda Yogarajah
Director

.........................................
Dominic Paviour
Director